🇺🇸 Colchcine in United States

12 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 20 April 2025 – 20 April 2026
• Total reports: 12

Most-reported reactions

1. Nausea — 2 reports (16.67%)
2. Vomiting — 2 reports (16.67%)
3. Abdominal Pain — 1 report (8.33%)
4. Abscess Intestinal — 1 report (8.33%)
5. Acidosis — 1 report (8.33%)
6. Arthralgia — 1 report (8.33%)
7. Back Pain — 1 report (8.33%)
8. Bacteriuria — 1 report (8.33%)
9. Balance Disorder — 1 report (8.33%)
10. Blood Glucose Increased — 1 report (8.33%)

Source database →

Frequently asked questions

Is Colchcine approved in United States?

Colchcine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Colchcine in United States?

Biogipuzkoa Health Research Institute is the originator. The local marketing authorisation holder may differ — check the official source linked above.